These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 36430270

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differential Expression of Inflammasome-Related Genes in Induced Pluripotent Stem-Cell-Derived Retinal Pigment Epithelial Cells with or without History of Age-Related Macular Degeneration.
    Hytti M, Korhonen E, Hongisto H, Kaarniranta K, Skottman H, Kauppinen A.
    Int J Mol Sci; 2021 Jun 24; 22(13):. PubMed ID: 34202702
    [Abstract] [Full Text] [Related]

  • 24. Nanomedicine-based Curcumin Approach Improved ROS Damage in Best Dystrophy-specific Induced Pluripotent Stem Cells.
    Lin TC, Lin YY, Hsu CC, Yang YP, Yang CH, Hwang DK, Wang CY, Liu YY, Lo WL, Chiou SH, Peng CH, Chen SJ, Chang YL.
    Cell Transplant; 2019 Nov 24; 28(11):1345-1357. PubMed ID: 31313605
    [Abstract] [Full Text] [Related]

  • 25. Pluripotent Stem Cell-Based Therapies in Combination with Substrate for the Treatment of Age-Related Macular Degeneration.
    Pennington BO, Clegg DO.
    J Ocul Pharmacol Ther; 2016 Jun 24; 32(5):261-71. PubMed ID: 26889704
    [Abstract] [Full Text] [Related]

  • 26. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.
    Hazim RA, Karumbayaram S, Jiang M, Dimashkie A, Lopes VS, Li D, Burgess BL, Vijayaraj P, Alva-Ornelas JA, Zack JA, Kohn DB, Gomperts BN, Pyle AD, Lowry WE, Williams DS.
    Stem Cell Res Ther; 2017 Oct 02; 8(1):217. PubMed ID: 28969679
    [Abstract] [Full Text] [Related]

  • 27. Polarization-sensitive optical coherence tomography for estimating relative melanin content of autologous induced stem-cell derived retinal pigment epithelium.
    Matsuzaki M, Mandai M, Yamanari M, Totani K, Nishida M, Sugita S, Maeda T, Koide N, Takagi S, Hirami Y, Miyamoto N, Sugiyama S, Takahashi M, Kurimoto Y.
    Sci Rep; 2020 May 06; 10(1):7656. PubMed ID: 32376945
    [Abstract] [Full Text] [Related]

  • 28. Experimental stem cell replacement transplantation in retinal pigment epithelium atrophy.
    Neroeva NV, Neroev VV, Katargina LA, Ryabina MV, Ilyukhin PA, Karmokova AG, Losanova OA, Maybogin AM, Kharitonov AE, Eremeev AV, Lagarkova MA.
    Vestn Oftalmol; 2022 May 06; 138(3):7-15. PubMed ID: 35801874
    [Abstract] [Full Text] [Related]

  • 29. Considerations for Developing an Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Retinal Pigment Epithelium (RPE) Replacement Therapy.
    Bose D, Ortolan D, Farnoodian M, Sharma R, Bharti K.
    Cold Spring Harb Perspect Med; 2024 Mar 01; 14(3):. PubMed ID: 37487631
    [Abstract] [Full Text] [Related]

  • 30. Generation and Differentiation of Induced Pluripotent Stem Cells from Mononuclear Cells in An Age-Related Macular Degeneration Patient.
    Wang T, Liu J, Chen J, Qin B.
    Cell J; 2022 Dec 01; 24(12):764-773. PubMed ID: 36527349
    [Abstract] [Full Text] [Related]

  • 31. Treatment of Age-Related Macular Degeneration with Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
    Vitillo L, Tovell VE, Coffey P.
    Curr Eye Res; 2020 Mar 01; 45(3):361-371. PubMed ID: 31777296
    [Abstract] [Full Text] [Related]

  • 32. Altered transcriptome and disease-related phenotype emerge only after fibroblasts harvested from patients with age-related macular degeneration are differentiated into retinal pigment epithelium.
    Cai H, Gong J, NYSCF Global Stem Cell Array TeamThe New York Stem Cell Foundation (NYSCF) Research Institute, 619 West 54th St., New York, NY, 10019, USA., Noggle S, Paull D, Rizzolo LJ, Del Priore LV, Fields MA.
    Exp Eye Res; 2021 Jun 01; 207():108576. PubMed ID: 33895162
    [Abstract] [Full Text] [Related]

  • 33. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
    Croze RH, Clegg DO.
    Dev Ophthalmol; 2014 Jun 01; 53():81-96. PubMed ID: 24732763
    [Abstract] [Full Text] [Related]

  • 34. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
    Hinkle JW, Mahmoudzadeh R, Kuriyan AE.
    Stem Cell Res Ther; 2021 Oct 11; 12(1):538. PubMed ID: 34635174
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Soy Protein Nanofiber Scaffolds for Uniform Maturation of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.
    Phelan MA, Kruczek K, Wilson JH, Brooks MJ, Drinnan CT, Regent F, Gerstenhaber JA, Swaroop A, Lelkes PI, Li T.
    Tissue Eng Part C Methods; 2020 Aug 11; 26(8):433-446. PubMed ID: 32635833
    [Abstract] [Full Text] [Related]

  • 40. Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery.
    Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Sharma R, Faura G, Eide L, Shanker Verma R, Znaor L, Erceg S, Stieger K, Motlik J, Petrovski G, Bharti K.
    Stem Cells Transl Med; 2023 Aug 16; 12(8):536-552. PubMed ID: 37459045
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.